Molecule Structure

Scientific Name

Riluzole

Description of the Drug

Riluzole is a glutamate antagonist used to treat amyotrophic lateral sclerosis.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00740

Brand Name(s)

Exservan, Rilutek, Riluzole, Teglutik, Tiglutik kit

Company Owner(s)

Apotex Corp, Alkem Laboratories Ltd, Kenton Chemicals And Pharmaceuticals Corp, Covis Pharma Gmbh, Sun Pharmaceutical Industries Ltd, Daito Pharmaceuticals Co Ltd, Aquestive Therapeutics Inc, Italfarmaco Sa, Glenmark Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Sodium channel alpha subunit PROTEIN FAMILY BLOCKER CHEMBL2331043

Unichem Links

SureChEMBL SCHEMBL78905
PharmGKB PA451251
Human Metabolome Database HMDB0014878
DrugBank DB00740
PubChem: Thomson Pharma 14773880
PubChem 5070
Mcule MCULE-9362288181
LINCS LSM-2471
Nikkaji J22.921K
PDBe 657
BindingDB 30705
EPA CompTox Dashboard DTXSID3045192
DrugCentral 2382
ChemicalBook CB3353226
Guide to Pharmacology 2326
rxnorm RILUZOLE EXSERVAN RILUTEK TIGLUTIK
PubChem: Drugs of the Future 12013649
KEGG Ligand C07937
ChEBI 8863
ZINC ZINC000000006481